Publications - Tait D . Shanafelt, M.D.

Back to Research Profile

1. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol 2009 Nov 06. [Epub ahead of print]
   View PubMed
2. Ding W, Nowakowski GS, Knox TR, Boysen JC, Maas ML, Schwager SM, Wu W, Wellik LE, Dietz AB, Ghosh AK, Secreto CR, Medina KL, Shanafelt TD, Zent CS, Call TG, Kay NE. Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression. Br J Haematol 2009 Nov; 147(4):471-83. Epub 2009 Sep 08.
   View PubMed
3. Beckman TJ, Reed DA, Shanafelt TD, West CP. Impact of Resident Well-Being and Empathy on Assessments of Faculty Physicians. J Gen Intern Med 2009 Oct 31. [Epub ahead of print]
   View PubMed
4. West CP, Dyrbye LN, Sloan JA, Shanafelt TD. Single Item Measures of Emotional Exhaustion and Depersonalization Are Useful for Assessing Burnout in Medical Professionals. J Gen Intern Med 2009 Oct 03. [Epub ahead of print]
   View PubMed
5. West CP, Tan AD, Habermann TM, Sloan JA, Shanafelt TD. Association of resident fatigue and distress with perceived medical errors. JAMA 2009 Sep 23; 302(12):1294-300.
   View PubMed
6. Shanafelt TD, Balch CM, Bechamps GJ, Russell T, Dyrbye L, Satele D, Collicott P, Novotny PJ, Sloan J, Freischlag JA. Burnout and career satisfaction among American surgeons. Ann Surg 2009 Sep; 250(3):463-71.
   View PubMed
7. Shanafelt TD, Byrd JC, LaPLant B, Zent CS, Call T, Secreto C, Grever MR, Lin TS, Kay NE. Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia. Br J Haematol 2009 Sep; 146(6):660-4. Epub 2009 Jul 10.
   View PubMed
8. Swetz KM, Harrington SE, Matsuyama RK, Shanafelt TD, Lyckholm LJ. Strategies for avoiding burnout in hospice and palliative medicine: peer advice for physicians on achieving longevity and fulfillment. J Palliat Med 2009 Sep; 12(9):773-7.
   View PubMed
9. Shanafelt TD, Byrd JC, LaPlant B, Zent CS, Call T, Secreto C, Grever MR, Lin TS, Kay NE. Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia. Br J Haematol 2009 Sep; 146(6):660-4.
   View PubMed
10. Swetz KM, Harrington SE, Matsuyama RK, Shanafelt TD, Lyckholm LJ. Strategies for avoiding burnout in hospice and palliative medicine: peer advice for physicians on achieving longevity and fulfillment. J Palliat Med 2009 Sep; 12(9):773-7.
    View PubMed
11. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009 Aug 20; 27(24):3959-63. Epub 2009 Jul 20.
    View PubMed
12. Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, Secreto CR, Ghosh AK, Kabat BF, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol 2009 Aug 10; 27(23):3808-14. Epub 2009 May 26.
    View PubMed
13. Tam CS, Shanafelt TD, Wierda WG, Abruzzo LV, Van Dyke DL, O'Brien S, Ferrajoli A, Lerner SA, Lynn A, Kay NE, Keating MJ. De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience. Blood 2009 Jul 30; 114(5):957-64. Epub 2009 May 04.
    View PubMed
14. Nowakowski GS, Shanafelt TD, Schwager S, Kay NE. Reply to R.S. Go. J Clin Oncol 2009 Jul 06. [Epub ahead of print]
    View PubMed
15. Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE, Lee YK, Mukhopadhyay D, Kay NE. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009 May 28; 113(22):5568-74. Epub 2009 Mar 31.
    View PubMed
16. Shanafelt TD, West CP, Sloan JA, Novotny PJ, Poland GA, Menaker R, Rummans TA, Dyrbye LN. Career fit and burnout among academic faculty. Arch Intern Med 2009 May 25; 169(10):990-5.
    View PubMed
17. Zent CS, Shanafelt T. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia. Leuk Lymphoma 2009 May 19; 1-2. [Epub ahead of print]
    View PubMed
18. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009 Apr 30; 113(18):4188-96. Epub 2008 Nov 17.
    View PubMed
19. Nowakowski GS, Hoyer JD, Shanafelt TD, Zent CS, Call TG, Bone ND, Laplant B, Dewald GW, Tschumper RC, Jelinek DF, Witzig TE, Kay NE. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia. J Clin Oncol 2009 Apr 10; 27(11):1844-9. Epub 2009 Mar 02.
    View PubMed
20. Kay NE, Shanafelt TD, Call TG, Wu W, Laplant BR. N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia. Leuk Lymphoma 2009 Apr; 50(4):588-92.
    View PubMed
21. Balch CM, Freischlag JA, Shanafelt TD. Stress and burnout among surgeons understanding and managing the syndrome and avoiding the adverse consequences. Arch Surg 2009 Apr; 144(4):371-6.
    View PubMed
22. Dyrbye LN, Shanafelt TD, Thomas MR, Durning SJ. Brief observation: a national study of burnout among internal medicine clerkship directors. Am J Med 2009 Mar; 122(3):310-2.
    View PubMed
23. Dyrbye LN, Thomas MR, Harper W, Massie FS Jr, Power DV, Eacker A, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. The learning environment and medical student burnout: a multicentre study. Med Educ 2009 Mar; 43(3):274-82.
    View PubMed
24. Shanafelt T, Hanson CA. Monoclonal B-cell lymphocytosis: definitions and natural history. Leuk Lymphoma 2009 Mar; 50(3):493-7.
    View PubMed
25. Ghosh AK, Kay NE, Secreto CR, Shanafelt TD. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin Cancer Res 2009 Feb 15; 15(4):1250-8.
    View PubMed
26. Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res 2009 Feb; 33(2):263-70. Epub 2008 Jul 25.
    View PubMed
27. Shanafelt TD, Jenkins G, Call TG, Zent CS, Slager S, Bowen DA, Schwager S, Hanson CA, Jelinek DF, Kay NE. Validation of a new prognostic index for patients with chronic lymphocytic leukemia. Cancer 2009 Jan 15; 115(2):363-72.
    View PubMed
28. Dyrbye LN, West CP, Shanafelt TD. Defining Burnout as a Dichotomous Variable. J Gen Intern Med 2009 Jan 6. [Epub Ahead of print]
    View PubMed
29. Kay NE, Shanafelt TD, Call TG, Wu WT, Laplant BR. N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50(4):588-92.
    View PubMed
30. Zent CS, Ding W, Reinalda MS, Schwager SM, Hoyer JD, Bowen DA, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Kay NE, Slager SL. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leuk Lymphoma 2009; 50(8):1261-8.
    View PubMed
31. Shanafelt TD, West CP, Poland GA, LaRusso NF, Menaker R, Bahn RS. Principles to promote physician satisfaction and work-life balance. Minn Med 2008 Dec; 91(12):41-3.
    View PubMed
32. Zent CS, Secreto CR, LaPlant BR, Bone ND, Call TG, Shanafelt TD, Jelinek DF, Tschumper RC, Kay NE. Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab. Leuk Res 2008 Dec; 32(12):1849-56. Epub 2008 Jun 27.
    View PubMed
33. Shanafelt T. In Reply: More on Burnout and Surgical Oncology. Ann Surg Oncol 2008 Nov 13. [Epub ahead of print]
    View PubMed
34. Zent CS, Call TG, Shanafelt TD, Tschumper RC, Jelinek DF, Bowen DA, Secreto CR, Laplant BR, Kabat BF, Kay NE. Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab. Cancer 2008 Oct 15; 113(8):2110-8.
    View PubMed
35. Dyrbye LN, Thomas MR, Massie FS, Power DV, Eacker A, Harper W, Durning S, Moutier C, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. Burnout and suicidal ideation among U.S. medical students. Ann Intern Med 2008 Sep 2; 149(5):334-41.
    View PubMed
36. Dyrbye LN, Thomas MR, Massie FS, Power DV, Eacker A, Harper W, Durning S, Moutier C, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. Burnout and suicidal ideation among U.S. medical students. Ann Intern Med 2008 Sep 2; 149(5):334-41.
    View PubMed
37. Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)? Leuk Res 2008 Sep; 32(9):1458-61. Epub 2008 Jan 07.
    View PubMed
38. Kuerer HM, Breslin T, Shanafelt TD, Baile WF, Crawford W, Balch CM. Road map for maintaining career satisfaction and balance in surgical oncology. J Am Coll Surg 2008 Sep; 207(3):435-42.
    View PubMed
39. Morice WG, Kurtin PJ, Hodnefield JM, Shanafelt TD, Hoyer JD, Remstein ED, Hanson CA. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc 2008 Jul; 83(7):776-85.
    View PubMed
40. Goitein L, Shanafelt TD, Nathens AB, Curtis JR. Effects of resident work hour limitations on faculty professional lives. J Gen Intern Med 2008 Jul; 23(7):1077-83.
    View PubMed
41. Nabhan C, Shanafelt TD, Kay NE. Controversies in the front-line management of chronic lymphocytic leukemia. Leuk Res 2008 May; 32(5):679-88. Epub 2008 Jan 11.
    View PubMed
42. Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM, Markovic SN, Call TG, Bowen DA, Jelinek DF, Kay NE, Shanafelt TD. Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia. Br J Haematol 2008 May; 141(5):607-14. Epub 2008 Apr 01.
    View PubMed
43. Zent CS, Ding W, Schwager SM, Reinalda MS, Hoyer JD, Jelinek DF, Tschumper RC, Bowen DA, Call TG, Shanafelt TD, Kay NE, Slager SL. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. Br J Haematol 2008 May; 141(5):615-21. Epub 2008 Mar 27.
    View PubMed
44. Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Br J Haematol 2008 Mar; 140(5):537-46.
    View PubMed
45. Shanafelt T. A career in surgical oncology: finding meaning, balance, and personal satisfaction. Ann Surg Oncol 2008 Feb; 15(2):400-6. Epub 2007 Dec 12.
    View PubMed
46. Tschumper RC, Geyer SM, Campbell ME, Kay NE, Shanafelt TD, Zent CS, Nowakowski GS, Call TG, Dewald GW, Jelinek DF. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. J Clin Invest 2008 Jan; 118(1):306-15.
    View PubMed
47. Thurmes P, Call T, Slager S, Zent C, Jenkins G, Schwager S, Bowen D, Kay N, Shanafelt T. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma 2008 Jan; 49(1):49-56.
    View PubMed
48. Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features. Leuk Lymphoma 2007 Dec; 48(12):2412-7.
    View PubMed
49. Browning RL, Geyer SM, Johnson AJ, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Zent CS, Bone ND, Dewald GW, Lin TS, Heerema NA, Grever MR, Kay NE, Byrd JC, Lucas DM. Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia. Leuk Res 2007 Dec; 31(12):1737-40. Epub 2007 Jul 19.
    View PubMed
50. Maddocks-Christianson K, Slager SL, Zent CS, Reinalda M, Call TG, Habermann TM, Bowen DA, Hoyer JD, Schwager S, Jelinek DF, Kay NE, Shanafelt TD. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. Br J Haematol 2007 Nov; 139(3):398-404.
    View PubMed
51. Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, Michelassi F, Singletary SE, Novotny P, Sloan J, Shanafelt TD. Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology. Ann Surg Oncol 2007 Nov; 14(11):3043-53. Epub 2007 Sep 09.
    View PubMed
52. Dyrbye LN, Thomas MR, Eacker A, Harper W, Massie FS Jr, Power DV, Huschka M, Novotny PJ, Sloan JA, Shanafelt TD. Race, ethnicity, and medical student well-being in the United States. Arch Intern Med 2007 Oct 22; 167(19):2103-9.
    View PubMed
53. Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Sloan JA, Call TG. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 2007 Oct; 139(2):255-64.
    View PubMed
54. West CP, Shanafelt TD. Physician well-being and professionalism. Minn Med 2007 Aug; 90(8):44-6.
    View PubMed
55. Dyrbye LN, Thomas MR, Mechaber AJ, Eacker A, Harper W, Massie FS Jr, Power DV, Shanafelt TD. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions. Acad Med 2007 Jul; 82(7):654-60.
    View PubMed
56. Kay NE, Shanafelt TD, Strege AK, Lee YK, Bone ND, Raza A. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch". Leuk Res 2007 Jul; 31(7):899-906. Epub 2007 Jan 22.
    View PubMed
57. Shanafelt TD, Lin T, Geyer SM, Zent CS, Leung N, Kabat B, Bowen D, Grever MR, Byrd JC, Kay NE. Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. Cancer 2007 Jun 1; 109(11):2291-8.
    View PubMed
58. West CP, Huntington JL, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. A prospective study of the relationship between medical knowledge and professionalism among internal medicine residents. Acad Med 2007 Jun; 82(6):587-92.
    View PubMed
59. Martin W, Abraham R, Shanafelt T, Clark RJ, Bone N, Geyer SM, Katzmann JA, Bradwell A, Kay NE, Witzig TE. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Transl Res 2007 Apr; 149(4):231-5.
    View PubMed
60. Nowakowski GS, Hoyer JD, Shanafelt TD, Geyer SM, LaPlant BR, Call TG, Jelinek DF, Zent CS, Kay NE. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test. Mayo Clin Proc 2007 Apr; 82(4):449-53.
    View PubMed
61. Thomas MR, Dyrbye LN, Huntington JL, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. How do distress and well-being relate to medical student empathy? A multicenter study. J Gen Intern Med 2007 Feb; 22(2):177-83.
    View PubMed
62. Kay NE, Geyer SM, Call TG, Shanafelt TD, Zent CS, Jelinek DF, Tschumper R, Bone ND, Dewald GW, Lin TS, Heerema NA, Smith L, Grever MR, Byrd JC. Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia. Blood 2007 Jan 15; 109(2):405-11. Epub 2006 Sep 28.
    View PubMed
63. West CP, Shanafelt TD. The influence of personal and environmental factors on professionalism in medical education. BMC Medical Education 2007; 7:29.
    View PubMed
64. Shanafelt TD, Kay NE. Comprehensive management of the CLL patient: a holistic approach. Hematology Am Soc Hematol Educ Program 2007; 324-31.
    View PubMed
65. Dyrbye LN, Thomas MR, Huschka MM, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students. Mayo Clin Proc 2006 Nov; 81(11):1435-42.
    View PubMed
66. Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006 Oct 1; 24(28):4634-41.
    View PubMed
67. Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med 2006 Sep 19; 145(6):435-47.
    View PubMed
68. West CP, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. JAMA 2006 Sep 6; 296(9):1071-8.
    View PubMed
69. Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE. Update on risk-stratified management for chronic lymphocytic leukemia. Leuk Lymphoma 2006 Sep; 47(9):1738-46.
    View PubMed
70. Shanafelt T, Chung H, White H, Lyckholm LJ. Shaping your career to maximize personal satisfaction in the practice of oncology. J Clin Oncol 2006 Aug 20; 24(24):4020-6.
    View PubMed
71. Shanafelt T, Kay N. T-cell abnormalities in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2006 Jul; 47(7):1197-8.
    View PubMed
72. Shanafelt TD, Lee YK, Call TG, Nowakowski GS, Dingli D, Zent CS, Kay NE. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res 2006 Jun; 30(6):707-12. Epub 2005 Dec 01.
    View PubMed
73. Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW. Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2006 Jun; 167(2):177-81.
    View PubMed
74. Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 2006 Apr 15; 166(2):152-6.
    View PubMed
75. Shanafelt TD, Kay NE. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol 2006 Apr; 33(2):174-85.
    View PubMed
76. Dyrbye LN, Thomas MR, Huntington JL, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. Personal life events and medical student burnout: a multicenter study. Acad Med 2006 Apr; 81(4):374-84.
    View PubMed
77. Dyrbye LN, Thomas MR, Shanafelt TD. Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and Canadian medical students. Acad Med 2006 Apr; 81(4):354-73.
    View PubMed
78. Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 2006 Feb 20; 24(6):983-7. Epub 2006 Jan 23.
    View PubMed
79. Shanafelt TD, West C, Zhao X, Novotny P, Kolars J, Habermann T, Sloan J. Relationship between increased personal well-being and enhanced empathy among internal medicine residents. J Gen Intern Med 2005 Jul; 20(7):559-64.
    View PubMed
80. Nowakowski GS, Dewald GW, Hoyer JD, Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED, Phyliky RL, Call TG, Shanafelt TD, Kay NE, Zent CS. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005 Jul; 130(1):36-42.
    View PubMed
81. Shanafelt TD, Lee YK, Bone ND, Strege AK, Narayanan VL, Sausville EA, Geyer SM, Kaufmann SH, Kay NE. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. Blood 2005 Mar 1; 105(5):2099-106. Epub 2004 Sep 23.
    View PubMed
82. Fink SR, Paternoster SF, Smoley SA, Flynn HC, Geyer SM, Shanafelt TD, Lee YK, Jelinek DF, Kay NE, Dewald GW. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leuk Res 2005 Mar; 29(3):253-62.
    View PubMed
83. Shanafelt TD, Loprinzi C, Marks R, Novotny P, Sloan J. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? J Clin Oncol 2004 May 15; 22(10):1966-74.
    View PubMed
84. Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004 Feb 15; 103(4):1202-10. Epub 2003 Oct 23.
    View PubMed
85. Shanafelt TD, Madueme HL, Wolf RC, Tefferi A. Rituximab for immune cytopenia in adults: Idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc 2003 Nov; 78(11):1340-6.
    View PubMed
86. Back A, Wipf J, Shanafelt T. Resident burnout. Ann Intern Med 2002 Oct 15; 137:700.
    View PubMed
87. Shanafelt TD, Bradley KA, Wipf JE, Back AL. Burnout and self-reported patient care in an internal medicine residency program. Ann Intern Med 2002 Mar 5; 136(5):358-67.
    View PubMed